Cell kinetics in acute leukemia: a critical reevaluation based on new data

Area of Science:

• Hematology
• Oncology
• Biomedical Engineering

Background:

• Accurate cell kinetic analysis is crucial for acute leukemia treatment.
• Evaluating sampling techniques and the clinical significance of cell kinetic data is essential.

Purpose of the Study:

• To compare biopsy and aspiration techniques for reliable cell kinetic analysis in acute leukemia.
• To reevaluate the clinical significance of cell kinetic data in acute nonlymphocytic leukemia (ANLL).

Main Methods:

• Comparison of 143 paired bone marrow aspirates and Jamshidi biopsies from 61 ANLL patients.
• Utilized flow cytometry (FCM) for DNA/RNA, autoradiography for 3H-TdR labeling index, and liquid scintillation counting for 3H-TdR uptake.

Main Results:

• Marrow aspirates showed unreliability for pretreatment evaluation and monitoring due to peripheral blood contamination.
• Jamshidi biopsy provides reliable bone marrow sampling for cell kinetic studies.
• FCM S-phase index from biopsy was not predictive of therapeutic response in 43 ANLL patients.
• Changes in FCM S-phase index after 48-hour cytosine arabinoside infusion correlated with clinical response in one protocol.

Conclusions:

• Bone marrow biopsy is recommended over aspiration for reliable cell kinetic studies in acute leukemia.
• Cell kinetic data, specifically FCM S-phase index from biopsy, has limited predictive value for therapeutic response in ANLL.
• Dynamic changes in FCM S-phase index during treatment may offer predictive insights in specific therapeutic regimens.